AstraZeneca plc ADR (AZN)


AstraZeneca is a prescription-based biopharmaceutical company. Co. discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology and Respiratory and Inflammation. Co. maintains a range of products which includes a number of key products such as: Arimidex (for breast cancer), Crestor (for managing cholesterol levels), Nexium (for acid reflux), Seroquel (for schizophrenia and bipolar disorder), Synagis (for RSV, a respiratory infection in infants) and Symbicort (for asthma and chronic obstructive pulmonary disease). Co. is active in over 100 countries.

View SEC Filings from AZN instead.
Filers who had this stock in their top 10: 4
13F Filers holding this stock: 387
Aggregate shares on 06/30/2016: 288,497,724
Aggregate shares on 03/31/2016: 257,553,502
Percent change: 12.01%
Funds creating new positions: 48
Funds Adding to an existing position: 151
Funds closing out their position: 38
Funds reducing their position: 97

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 06/30/2016

Subscription required

Click here to report any possible errors with this stock listing.

Elevate your investments

or Learn more